Haw Par Corporation Ltd
SGX:H02
Haw Par Corporation Ltd
SGX:H02
Price:
9.64 SGD
-2.13%
Market Closed
Updated:
May 4, 2024
Haw Par Corporation Ltd
Cash from Investing Activities
|
Haw Par Corporation Ltd
Cash from Investing Activities Peer Comparison
Comparables:
WVE
H
1J5
I
42C
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cash from Investing Activities
S$258m
|
CAGR 3-Years
23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
61%
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cash from Investing Activities
-$1.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cash from Investing Activities
-S$1.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Cash from Investing Activities
S$704k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Haw Par Corporation Ltd's Cash from Investing Activities?
Cash from Investing Activities
258m
SGD
258m
SGD
Based on the financial report for Dec 31, 2023, Haw Par Corporation Ltd's Cash from Investing Activities amounts to 258m SGD.
What is Haw Par Corporation Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
61%
61%
The average annual Cash from Investing Activities growth rates for Haw Par Corporation Ltd have been 23% over the past three years , 16% over the past five years , and 61% over the past ten years .
You don't have any saved screeners yet
